| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Zaal Kokaia | |
| Olle Lindvall | |||
| P2860 | cites work | Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. | Q24534130 |
| Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia | Q24569823 | ||
| Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model | Q24631645 | ||
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Evidence for stroke-induced neurogenesis in the human brain | Q24678200 | ||
| Spinal cord injury reveals multilineage differentiation of ependymal cells | Q27333067 | ||
| Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome | Q28235047 | ||
| Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury | Q28250167 | ||
| Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease | Q28275257 | ||
| Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model | Q28344741 | ||
| Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery | Q28475604 | ||
| Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo | Q28507231 | ||
| Fezl is required for the birth and specification of corticospinal motor neurons | Q28586952 | ||
| Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 | ||
| Mechanisms and functional implications of adult neurogenesis | Q29547295 | ||
| Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation | Q29615640 | ||
| Neuronal replacement from endogenous precursors in the adult brain after stroke | Q29615772 | ||
| Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 | ||
| Directed differentiation of embryonic stem cells into motor neurons | Q29616200 | ||
| Transplantation of embryonic dopamine neurons for severe Parkinson's disease | Q29617304 | ||
| Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease | Q29619506 | ||
| Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease | Q30478932 | ||
| Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice | Q30480781 | ||
| Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice | Q30491245 | ||
| Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats | Q30581117 | ||
| Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. | Q30833707 | ||
| Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model | Q30841172 | ||
| Cell therapy in Parkinson's disease | Q33212017 | ||
| Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model | Q33269334 | ||
| Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord | Q33273600 | ||
| GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. | Q33292690 | ||
| Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum | Q33293607 | ||
| Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration | Q33387798 | ||
| Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury | Q33421738 | ||
| Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. | Q33565361 | ||
| Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. | Q33713837 | ||
| Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation | Q40544827 | ||
| Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease | Q42188656 | ||
| Stroke-induced neurogenesis in aged brain | Q42480928 | ||
| Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial | Q42483132 | ||
| Transplantation of cultured human neuronal cells for patients with stroke | Q42492334 | ||
| In vitro generation and transplantation of precursor-derived human dopamine neurons | Q43700682 | ||
| Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. | Q44037381 | ||
| Rat forebrain neurogenesis and striatal neuron replacement after focal stroke | Q44226820 | ||
| A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease | Q44571920 | ||
| Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms | Q44736716 | ||
| Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. | Q44816539 | ||
| Specification of motoneurons from human embryonic stem cells. | Q45246951 | ||
| A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease | Q45883058 | ||
| Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice | Q45887127 | ||
| Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia | Q46253405 | ||
| Directed evolution of motor neurons from genetically engineered neural precursors | Q46477359 | ||
| Functional integration of newly generated neurons into striatum after cerebral ischemia in the adult rat brain. | Q46477375 | ||
| Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells | Q46730802 | ||
| Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease | Q46803369 | ||
| Identification of intrinsic determinants of midbrain dopamine neurons | Q46913434 | ||
| Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats | Q47847785 | ||
| Endogenous neurogenesis in the human brain following cerebral infarction | Q48185382 | ||
| Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model. | Q48199408 | ||
| Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats | Q48242730 | ||
| Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke | Q48262046 | ||
| Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression | Q48305268 | ||
| Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. | Q48326932 | ||
| Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain. | Q48338775 | ||
| IGF-I specifically enhances axon outgrowth of corticospinal motor neurons | Q48389957 | ||
| Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. | Q48396299 | ||
| Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice. | Q48410700 | ||
| Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats | Q48417804 | ||
| Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. | Q48482142 | ||
| Dyskinesias following neural transplantation in Parkinson's disease | Q48590785 | ||
| Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. | Q48600819 | ||
| Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients | Q48681632 | ||
| Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin | Q48699328 | ||
| Persistent production of neurons from adult brain stem cells during recovery after stroke. | Q48739755 | ||
| Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats | Q48752451 | ||
| Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia | Q48852632 | ||
| Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. | Q50610700 | ||
| Transplanted mouse embryonic stem-cell-derived motoneurons form functional motor units and reduce muscle atrophy. | Q50612517 | ||
| Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. | Q50707969 | ||
| Motoneurons derived from embryonic stem cells express transcription factors and develop phenotypes characteristic of medial motor column neurons. | Q50735935 | ||
| Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. | Q51986995 | ||
| Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. | Q52592016 | ||
| Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke | Q80399919 | ||
| Stem cell treatment in Amyotrophic Lateral Sclerosis | Q80507987 | ||
| Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis | Q81541349 | ||
| Autologous mesenchymal stem cell transplantation in stroke patients | Q81803888 | ||
| Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine | Q82764821 | ||
| Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease | Q33726762 | ||
| Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. | Q33925878 | ||
| Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease | Q34118080 | ||
| Increased hippocampal neurogenesis in Alzheimer's disease. | Q34281877 | ||
| Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. | Q34416128 | ||
| Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 | ||
| Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. | Q34538268 | ||
| Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke | Q34949959 | ||
| Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. | Q35094909 | ||
| Failure of neuronal maturation in Alzheimer disease dentate gyrus | Q35327913 | ||
| Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough | Q35751844 | ||
| Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation | Q35789004 | ||
| Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice | Q36334459 | ||
| Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. | Q36491400 | ||
| Regenerating the brain | Q36687833 | ||
| Neural stem/precursor cells for the treatment of ischemic stroke. | Q36870255 | ||
| Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat | Q37019997 | ||
| I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat | Q37020088 | ||
| Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia | Q37020101 | ||
| Stem and progenitor cell therapies: recent progress for spinal cord injury repair | Q37127835 | ||
| Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells | Q37164421 | ||
| Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS | Q37183861 | ||
| Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model | Q37184529 | ||
| Stem cells for spinal cord repair | Q37204415 | ||
| Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease | Q37221341 | ||
| Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules | Q37254921 | ||
| Is it too soon for mesenchymal stem cell trials in people with ALS? | Q37279972 | ||
| Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease | Q37300209 | ||
| Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic | Q37307355 | ||
| Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry | Q37307371 | ||
| Stem cell therapy in stroke. | Q37319445 | ||
| Generation of spinal motor neurons from human fetal brain-derived neural stem cells: role of basic fibroblast growth factor | Q37335277 | ||
| Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke | Q37354712 | ||
| Why have we failed to achieve neuroprotection in Parkinson's disease? | Q37363916 | ||
| Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. | Q37416265 | ||
| Stem cell-based cell therapy in neurological diseases: a review | Q37419268 | ||
| Cell therapy for CNS trauma | Q37426384 | ||
| Therapeutic cloning in individual parkinsonian mice | Q37449986 | ||
| Microglia in ALS: the good, the bad, and the resting | Q37592030 | ||
| Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. | Q39311874 | ||
| Factors affecting the clinical outcome after neural transplantation in Parkinson's disease | Q39360071 | ||
| Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient | Q39434658 | ||
| VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. | Q39835764 | ||
| Directed differentiation of human-induced pluripotent stem cells generates active motor neurons | Q39863440 | ||
| Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells | Q39910905 | ||
| Effects of human neural stem cell transplantation in canine spinal cord hemisection | Q40010874 | ||
| Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis | Q40035096 | ||
| Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm | Q40139859 | ||
| L3/Lhx8 is a pivotal factor for cholinergic differentiation of murine embryonic stem cells. | Q40167536 | ||
| Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. | Q40216832 | ||
| Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats | Q40220494 | ||
| Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats | Q40250561 | ||
| Recovery from paralysis in adult rats using embryonic stem cells. | Q40262579 | ||
| A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke | Q40319588 | ||
| Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates | Q40339968 | ||
| GDNF delivery using human neural progenitor cells in a rat model of ALS. | Q40425197 | ||
| The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons. | Q40462051 | ||
| Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation | Q40493282 | ||
| Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor | Q40504543 | ||
| Functional properties of motoneurons derived from mouse embryonic stem cells. | Q40517622 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 29-40 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Stem cells in human neurodegenerative disorders--time for clinical translation? | |
| P478 | volume | 120 |
| Q88923991 | 3D bioprinter applied picosecond pulsed electric fields for targeted manipulation of proliferation and lineage specific gene expression in neural stem cells |
| Q100314972 | A Trimodal Ultrasound, Photoacoustic and Magnetic Resonance Imaging Approach for Longitudinal Post-operative Monitoring of Stem Cells in the Spinal Cord |
| Q55396812 | A model of hematopoietic bone marrow apoptosis during growth factor deprivation in combination with a cytokine. |
| Q38781123 | A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs). |
| Q35214817 | A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs). |
| Q35169918 | Acupuncture: a potent therapeutic tool for inducing adult neurogenesis |
| Q38873789 | Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies |
| Q39342788 | Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease. |
| Q38332493 | Adult human neural stem cell therapeutics: Current developmental status and prospect |
| Q36861593 | Adult human olfactory epithelial-derived progenitors: a potential autologous source for cell-based treatment for Parkinson's disease |
| Q38168862 | Adult neurogenesis and its role in neuropsychiatric disease, brain repair and normal brain function |
| Q91792094 | Adult neurogenesis: Is it showtime for clinical translation? |
| Q41877527 | Aging and neurogenesis, a lesion from Alzheimer's disease. |
| Q34033021 | Allopregnanolone and neurogenesis in the nigrostriatal tract |
| Q27334826 | Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease |
| Q37361564 | Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling |
| Q38160459 | Amyotrophic lateral sclerosis: applications of stem cells - an update. |
| Q35224557 | ApoE is required for maintenance of the dentate gyrus neural progenitor pool |
| Q37432078 | Apoptosis signal-regulating kinase 1 (ASK1) is linked to neural stem cell differentiation after ischemic brain injury |
| Q28076197 | Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders |
| Q35673895 | Aptamer technology for tracking cells' status & function |
| Q41226076 | Astrocyte reactivity after brain injury-: The role of galectins 1 and 3. |
| Q41452682 | Bcl-2 enhances the formation of newborn striatal long-projection neurons in adult rat brain after a transient ischemic stroke |
| Q51546444 | Biogrid--a microfluidic device for large-scale enzyme-free dissociation of stem cell aggregates. |
| Q45871821 | Bone marrow-derived mesenchymal stem cells expressing the bFGF transgene promote axon regeneration and functional recovery after spinal cord injury in rats |
| Q59137766 | Brain Plasticity in Mammals: An Example for the Role of Comparative Medicine in the Neurosciences |
| Q52315021 | Brain and spinal cord injury repair by implantation of human neural progenitor cells seeded onto polymer scaffolds. |
| Q36554467 | Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells |
| Q36587910 | Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression. |
| Q47793278 | Caspase-3 modulates regenerative response after stroke |
| Q51762402 | Cell Replacement to Reverse Brain Aging: Challenges, Pitfalls, and Opportunities. |
| Q37921767 | Cell replacement therapy for Parkinson's disease: how close are we to the clinic? |
| Q38079793 | Cell therapy for Parkinson's disease: what next? |
| Q44297524 | Cell transplantation and gene therapy in Parkinson's disease |
| Q28730429 | Cellular host responses to gliomas |
| Q42363724 | Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern |
| Q37972875 | Chemical and topographical patterning of hydrogels for neural cell guidance in vitro |
| Q36204514 | Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury |
| Q38697315 | Clinical translation of stem cells in neurodegenerative disorders. |
| Q28484677 | Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research |
| Q33882998 | Comparison of Nutech Functional Score with European Stroke Scale for Patients with Cerebrovascular Accident Treated with Human Embryonic Stem Cells: NFS for CVA Patients Treated with hESCs |
| Q38063851 | Concise review: self-renewal in the central nervous system: neural stem cells from embryo to adult. |
| Q34310248 | Constraint-induced movement therapy as a paradigm of translational research in neurorehabilitation: Reviews and prospects |
| Q91806326 | Constructing temporal regulatory cascades in the context of development and cell differentiation |
| Q38752501 | Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus |
| Q38029969 | Cross-talk between neural stem cells and immune cells: the key to better brain repair? |
| Q52568314 | Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. |
| Q26861926 | Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review |
| Q42738980 | Delayed hyperbaric oxygen therapy promotes neurogenesis through reactive oxygen species/hypoxia-inducible factor-1α/β-catenin pathway in middle cerebral artery occlusion rats |
| Q37756518 | Designing customized cell signalling circuits |
| Q37217325 | Development and application of neural stem cells for treating various human neurological diseases in animal models |
| Q38105080 | Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies |
| Q34072824 | Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model |
| Q37239718 | Differentiation and Molecular Properties of Mesenchymal Stem Cells Derived from Murine Induced Pluripotent Stem Cells Derived on Gelatin or Collagen. |
| Q39663866 | Differentiation of human neural progenitor cells regulated by Wnt-3a |
| Q47320169 | Differentiation of mesenchymal stem cells into neuron-like cells using composite 3D scaffold combined with valproic acid induction |
| Q51839740 | Direct GSK-3β inhibition enhances mesenchymal stromal cell migration by increasing expression of β-PIX and CXCR4. |
| Q42773447 | Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells |
| Q38195398 | Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy |
| Q39279039 | Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks |
| Q37513881 | Distributed Features of Vimentin-Containing Neural Precursor Cells in Olfactory Bulb of SOD1G93A Transgenic Mice: a Study about Resource of Endogenous Neural Stem Cells. |
| Q35945343 | Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome? |
| Q29615682 | Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease |
| Q36842220 | Dopamine receptors in human embryonic stem cell neurodifferentiation. |
| Q83199769 | Dopaminergic neurons for Parkinson's therapy |
| Q34376698 | Dynamic mass redistribution assay decodes differentiation of a neural progenitor stem cell |
| Q60046957 | Editorial: Adult Neurogenesis: Beyond Rats and Mice |
| Q48544863 | Effect of polyvinylidene fluoride electrospun fiber orientation on neural stem cell differentiation. |
| Q33781107 | Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair |
| Q37517917 | Effects of intravenous human umbilical cord blood CD34+ stem cell therapy versus levodopa in experimentally induced Parkinsonism in mice. |
| Q59101361 | Efficient reprogramming of mouse fibroblasts to neuronal cells including dopaminergic neurons |
| Q39282606 | Embryonic stem cell-derived neural stem cells fuse with microglia and mature neurons. |
| Q34687557 | Endogenous WNT signaling regulates hPSC-derived neural progenitor cell heterogeneity and specifies their regional identity |
| Q35178506 | Endogenously EGFP-Labeled Mouse Embryonic Stem Cells |
| Q34885564 | Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease |
| Q35697100 | Engrafted Neural Stem/Progenitor Cells Promote Functional Recovery through Synapse Reorganization with Spared Host Neurons after Spinal Cord Injury. |
| Q38172120 | Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives |
| Q26865616 | Epidermal growth factor, from gene organization to bedside |
| Q34627684 | Estrogen Enhances Neurogenesis and Behavioral Recovery after Stroke |
| Q41768916 | Evaluation of neural gene expression in serum treated embryonic stem cells in Alzheimer's patients |
| Q37858878 | Ex vivo gene transfer and correction for cell-based therapies |
| Q36482236 | Fantasies about stem cell therapy in chronic ischemic stroke patients |
| Q42084557 | Fate of transplanted bone marrow derived mesenchymal stem cells following spinal cord injury in rats by transplantation routes |
| Q34232844 | Fetal stem cell transplantation: Past, present, and future. |
| Q38889816 | Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging |
| Q34916199 | Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells in vivo |
| Q34586090 | Galectin-1 is expressed in early-type neural progenitor cells and down-regulates neurogenesis in the adult hippocampus |
| Q90788805 | Generation and post-injury integration of human spinal cord neural stem cells |
| Q26765258 | Generation of diverse neural cell types through direct conversion |
| Q92418503 | Glial Cell Line-derived Neurotrophic Factor-overexpressing Human Neural Stem/Progenitor Cells Enhance Therapeutic Efficiency in Rat with Traumatic Spinal Cord Injury |
| Q93173865 | Harnessing stem cells and biomaterials to promote neural repair |
| Q90354741 | High-Dose Neural Stem/Progenitor Cell Transplantation Increases Engraftment and Neuronal Distribution and Promotes Functional Recovery in Rats after Acutely Severe Spinal Cord Injury |
| Q27008225 | High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke |
| Q33732756 | High-resolution bioelectrical imaging of Aβ-induced network dysfunction on CMOS-MEAs for neurotoxicity and rescue studies. |
| Q26995364 | How do immune cells support and shape the brain in health, disease, and aging? |
| Q33620143 | How neurogenesis finds its place in a hardwired sensory system |
| Q36319845 | Human Umbilical Tissue-Derived Cells Promote Synapse Formation and Neurite Outgrowth via Thrombospondin Family Proteins |
| Q30541296 | Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. |
| Q39298289 | Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain |
| Q39299435 | Human midbrain precursors activate the expected developmental genetic program and differentiate long-term to functional A9 dopamine neurons in vitro. Enhancement by Bcl-X(L). |
| Q33638440 | Human motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse model |
| Q35176654 | Human neural stem cell transplantation in ALS: initial results from a phase I trial |
| Q36490240 | Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss |
| Q54625251 | Human umbilical cord blood-derived mesenchymal stem cells protect against neuronal cell death and ameliorate motor deficits in Niemann Pick type C1 mice. |
| Q47312408 | Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells. |
| Q87424282 | Icariin promotes self-renewal of neural stem cells: an involvement of extracellular regulated kinase signaling pathway |
| Q36129036 | Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment |
| Q30413268 | Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells |
| Q36374324 | Immunological regulation of neurogenic niches in the adult brain |
| Q45360064 | Impact of Theiler's virus infection on hippocampal neuronal progenitor cells: differential effects in two mouse strains |
| Q40612581 | In Vitro Conditioned Bone Marrow-Derived Mesenchymal Stem Cells Promote De Novo Functional Enteric Nerve Regeneration, but Not Through Direct-Transdifferentiation |
| Q46495043 | In Vivo Imaging of CNS Injury and Disease |
| Q36061125 | In Vivo Non-Invasive Tracking of Macrophage Recruitment to Experimental Stroke |
| Q37315468 | In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression |
| Q34359066 | In vitro expanded stem cells from the developing retina fail to generate photoreceptors but differentiate into myelinating oligodendrocytes |
| Q57158207 | In vitro studies on space-conforming self-assembling silk hydrogels as a mesenchymal stem cell-support matrix suitable for minimally invasive brain application |
| Q27022196 | In vivo imaging of endogenous neural stem cells in the adult brain |
| Q26753150 | Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging |
| Q64054563 | Inhibition of miRNA-27b enhances neurogenesis via AMPK activation in a mouse ischemic stroke model |
| Q38733954 | Initial graft size and not the innate immune response limit survival of engrafted neural stem cells |
| Q39189306 | Insights into cell-free therapeutic approach: Role of stem cell "soup-ernatant". |
| Q36411048 | Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. |
| Q31059372 | Interplay between cell migration and neurite outgrowth determines SH2B1β-enhanced neurite regeneration of differentiated PC12 cells |
| Q30459032 | Intracerebral neural stem cell transplantation improved the auditory of mice with presbycusis |
| Q48585796 | Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I). |
| Q58255075 | Intracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the Brain |
| Q58124033 | Intraparenchymal Neural Stem/Progenitor Cell Transplantation for Ischemic Stroke Animals: A Meta-Analysis and Systematic Review |
| Q33897794 | Involvement of beta1-integrin up-regulation in basic fibroblast growth factor- and epidermal growth factor-induced proliferation of mouse neuroepithelial cells. |
| Q42291750 | In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells |
| Q58862267 | La transdifférenciation cellulaire au service de la sclérose latérale amyotrophique ? |
| Q50283926 | Labeling of Luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo. |
| Q33618095 | Lack of riluzole efficacy in the progression of the neurodegenerative phenotype in a new conditional mouse model of striatal degeneration |
| Q27304388 | Learning-induced synaptic potentiation in implanted neural precursor cell-derived neurons |
| Q33684997 | Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF. |
| Q34530719 | Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports |
| Q39038123 | Long-term effects of magnetically targeted ferumoxide-labeled human neural stem cells in focal cerebral ischemia |
| Q42317100 | Magnetic Resonance Imaging of Ferumoxytol-Labeled Human Mesenchymal Stem Cells in the Mouse Brain |
| Q38222504 | Mechanotransduction: tuning stem cells fate |
| Q35849852 | Meeting the need for regenerative therapies I: target-based incidence and its relationship to U.S. spending, productivity, and innovation |
| Q26785623 | Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q38086083 | Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? |
| Q41878738 | Messenger RNA Expression Patterns of Neurotrophins during Transdifferentiation of Stem Cells from Human-Exfoliated Deciduous Teeth into Neural-like Cells |
| Q48690916 | MicroRNA-34a Modulates Neural Stem Cell Differentiation by Regulating Expression of Synaptic and Autophagic Proteins. |
| Q59136987 | MicroRNAs Engage in Complex Circuits Regulating Adult Neurogenesis |
| Q38187574 | NK cells after transplantation: friend or foe. |
| Q39314365 | Nanoengineering neural stem cells on biomimetic substrates using magnetofection technology. |
| Q34352877 | Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts |
| Q36136023 | Neural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: light and electron microscopic observations |
| Q40884175 | Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis |
| Q35590505 | Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy. |
| Q37739742 | Neural stem cells and strategies for the regeneration of the central nervous system |
| Q38057868 | Neural stem cells and stroke |
| Q41884863 | Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. |
| Q28264037 | Neural stem cells, adult neurogenesis, and galectin-1: from bench to bedside |
| Q38521764 | Neural stem cells: ready for therapeutic applications? |
| Q42065629 | Neurodegenerative Disease: A Perspective on Cell-Based Therapy in the New Era of Cell-Free Nano-Therapy |
| Q28307113 | Neurodegenerative disease and adult neurogenesis |
| Q38721612 | Neurogenin-2-transduced human neural progenitor cells attenuate neonatal hypoxic-ischemic brain injury |
| Q89036230 | Neuronal and Glial Differentiation of Human Neural Stem Cells Is Regulated by Amyloid Precursor Protein (APP) Levels |
| Q36950735 | Neuroplasticity in the context of motor rehabilitation after stroke. |
| Q35910744 | New considerations in the design of clinical trials for amyotrophic lateral sclerosis |
| Q36563408 | New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies |
| Q64957093 | Newly Generated and Non-Newly Generated "Immature" Neurons in the Mammalian Brain: A Possible Reservoir of Young Cells to Prevent Brain Aging and Disease? |
| Q92778200 | Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients |
| Q48655751 | Novel bimodal iron oxide particles for efficient tracking of human neural stem cells in vivo |
| Q37945678 | Novel paths towards neural cellular products for neurological disorders |
| Q37835900 | Nuclear receptors and microRNAs: Who regulates the regulators in neural stem cells? |
| Q35882540 | Oleanolic Acid Induces Differentiation of Neural Stem Cells to Neurons: An Involvement of Transcription Factor Nkx-2.5. |
| Q35559206 | Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain |
| Q58103551 | Optimized Clump Culture Methods for Adult Human Multipotent Neural Cells |
| Q30829270 | Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model |
| Q98771582 | Oriented Neural Spheroid Formation and Differentiation of Neural Stem Cells Guided by Anisotropic Inverse Opals |
| Q35611511 | Oxidative stress, redox regulation and diseases of cellular differentiation |
| Q33712879 | PACAP Promotes Matrix-Driven Adhesion of Cultured Adult Murine Neural Progenitors |
| Q38718614 | Paracrine Maturation and Migration of SH-SY5Y Cells by Dental Pulp Stem Cells |
| Q34282729 | Pathophysiologic cascades in ischemic stroke |
| Q37964983 | Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration. |
| Q92518340 | Physiological and pathological effects of amyloid-β species in neural stem cell biology |
| Q52589683 | Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. |
| Q33851241 | Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty |
| Q41814387 | Preparation of N-Phenyl-lactam Derivatives Capable of Stimulating Neurogenesis and Their Use in the Treatment of Neurological Disorders |
| Q35983132 | Progenitor cell-based treatment of the pediatric myelin disorders |
| Q38107439 | Progress in stem cell therapy for major human neurological disorders. |
| Q48895003 | Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications |
| Q27010398 | Promoting remyelination in multiple sclerosis-recent advances |
| Q47591395 | Protection of murine neural progenitor cells by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin in the low nanomolar concentration range |
| Q90642363 | Prussian blue nanocubes as a multimodal contrast agent for image-guided stem cell therapy of the spinal cord |
| Q37606452 | Pulp cell tracking by radionuclide imaging for dental tissue engineering. |
| Q33683005 | Quality and freshness of human bone marrow-derived mesenchymal stem cells decrease over time after trypsinization and storage in phosphate-buffered saline |
| Q37086202 | Radially branched deployment for more efficient cell transplantation at the scale of the human brain. |
| Q36421297 | Rapid generation of sub-type, region-specific neurons and neural networks from human pluripotent stem cell-derived neurospheres |
| Q92478922 | Recent Progress in the Regeneration of Spinal Cord Injuries by Induced Pluripotent Stem Cells |
| Q30424375 | Recognition and control of the progression of age-related hearing loss |
| Q37811884 | Recognition of cellular implants by the brain's innate immune system. |
| Q33854353 | Recruiting adaptive cellular stress responses for successful brain ageing |
| Q37864499 | Regenerative medicine for stroke - are we there yet? |
| Q38261543 | Remyelinating strategies in multiple sclerosis |
| Q92140095 | Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome |
| Q36196143 | Rhesus monkey neural stem cell transplantation promotes neural regeneration in rats with hippocampal lesions. |
| Q47703114 | Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells |
| Q38001423 | Role of SDF1/CXCR4 interaction in experimental hemiplegic models with neural cell transplantation |
| Q37922875 | Roles for HIF-1α in neural stem cell function and the regenerative response to stroke. |
| Q57556336 | Rotary orbital suspension culture of embryonic stem cell-derived neural stem/progenitor cells: impact of hydrodynamic culture on aggregate yield, morphology and cell phenotype |
| Q92712916 | Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases |
| Q41220881 | Safflower Seed Oil, Containing Oleic Acid and Palmitic Acid, Enhances the Stemness of Cultured Embryonic Neural Stem Cells through Notch1 and Induces Neuronal Differentiation |
| Q48448566 | Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. |
| Q35902185 | Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion |
| Q27335199 | Sensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene Transduction |
| Q38748983 | Simulation of developing human neuronal cell networks. |
| Q92556504 | Soluble Nogo receptor 1 fusion protein protects neural progenitor cells in rats with ischemic stroke |
| Q49122473 | Spatio-temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain |
| Q38252939 | Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes. |
| Q35840661 | Stem cell applications in military medicine |
| Q37954422 | Stem cell challenges in the treatment of neurodegenerative disease. |
| Q38058140 | Stem cell models of Alzheimer's disease and related neurological disorders |
| Q38211724 | Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease |
| Q36301821 | Stem cell therapy for amyotrophic lateral sclerosis |
| Q26995278 | Stem cell transplantation for motor neuron disease: current approaches and future perspectives |
| Q37800936 | Stem cell-derived neurotrophic support for the neuromuscular junction in spinal muscular atrophy. |
| Q38580609 | Stem cells for therapy in TBI. |
| Q38630465 | Stem cells therapy for ALS. |
| Q37668947 | Stem cells: roadmap to the clinic |
| Q48409935 | Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative. |
| Q34324040 | Synergistic contribution of SMAD signaling blockade and high localized cell density in the differentiation of neuroectoderm from H9 cells |
| Q33599129 | Syringe needle skull penetration reduces brain injuries and secondary inflammation following intracerebral neural stem cell transplantation |
| Q92394719 | Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases |
| Q38769589 | Tauroursodeoxycholic Acid Enhances Mitochondrial Biogenesis, Neural Stem Cell Pool, and Early Neurogenesis in Adult Rats |
| Q36554957 | Temporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats |
| Q38223428 | The (real) neurogenic/gliogenic potential of the postnatal and adult brain parenchyma |
| Q90009644 | The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer's Disease |
| Q38078024 | The challenges of translating stem cells for spinal cord injury and related disorders: what are the barriers and opportunities? |
| Q39740575 | The co-transduction of Nurr1 and Brn4 genes induces the differentiation of neural stem cells into dopaminergic neurons |
| Q37790600 | The impact of the Orphan Drug Act on the development and advancement of neurological products for rare diseases: a descriptive review |
| Q28568768 | The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms |
| Q36974665 | The pharmacology of regenerative medicine |
| Q38213991 | The potential of mesenchymal stem cell in prion research. |
| Q36776231 | The promise and perils of stem cell therapeutics |
| Q44623113 | Therapeutic activities of engrafted neural stem/precursor cells are not dormant in the chronically injured spinal cord |
| Q38457643 | Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion. |
| Q92738249 | Therapeutic effect of transplantation of human bone marrow‑derived mesenchymal stem cells on neuron regeneration in a rat model of middle cerebral artery occlusion |
| Q48639806 | Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice |
| Q50420577 | Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings. |
| Q41180607 | Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice |
| Q38457655 | Therapeutic potential of human induced pluripotent stem cells in experimental stroke |
| Q38921243 | Therapeutic potential of neural stem cells: greater in people's perception than in their brains? |
| Q27008479 | Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review |
| Q48109614 | Three-dimensional culture of single embryonic stem-derived neural/stem progenitor cells in fibrin hydrogels: neuronal network formation and matrix remodelling |
| Q39615475 | Three-dimensional growth matrix for human embryonic stem cell-derived neuronal cells |
| Q39308308 | Toll-interacting protein deficiency promotes neurodegeneration via impeding autophagy completion in high-fat diet-fed ApoE-/- mouse model |
| Q33797532 | Towards translational therapies for multiple system atrophy |
| Q43213548 | Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease. |
| Q34279124 | Tracking stem cell differentiation in the setting of automated optogenetic stimulation |
| Q64764573 | Transcriptome and proteome profiling of neural stem cells from the human subventricular zone in Parkinson's disease |
| Q38957847 | Transfection of the glial cell line-derived neurotrophic factor gene promotes neuronal differentiation |
| Q35549624 | Transplantation of human neural stem/progenitor cells overexpressing galectin-1 improves functional recovery from focal brain ischemia in the Mongolian gerbil |
| Q33863539 | Transplantation of neural differentiated human mesenchymal stem cells into the cochlea of an auditory-neuropathy guinea pig model |
| Q26825854 | Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury |
| Q42055739 | Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. |
| Q36790753 | Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells |
| Q48713811 | Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells |
| Q33825966 | Ultrasound-mediated piezoelectric differentiation of neuron-like PC12 cells on PVDF membranes |
| Q41332082 | Using magnetic nanoparticles for gene transfer to neural stem cells: stem cell propagation method influences outcomes |
| Q35077617 | Varicella-zoster virus infection of differentiated human neural stem cells |
| Q35036530 | Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging |
| Q35470460 | Vision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease |
| Q34714347 | What can pluripotent stem cells teach us about neurodegenerative diseases? |
| Q34033246 | Why is it so difficult to derive pluripotent stem cells in domestic ungulates? |
| Q34155662 | cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
Search more.